SCHEMBL8378247

SCHEMBL8378247

OCCc1ccccc1C1OCCO1

nearest known ligand 0.34

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.34
KIF11 P52732 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9518709 0.86 CYSLTR2 (0.37) TDP1
SCHEMBL11342700 0.85 APOBEC3G (0.38) TDP1
SCHEMBL8938495 0.78 HTR5A (0.32) TDP1
SCHEMBL6156151 0.78 APOBEC3G (0.35) TDP1
SCHEMBL11081681 0.77 HTR2C (0.34)
SCHEMBL28432972 0.77 CYP2A13 (0.30)
SCHEMBL11941061 0.77 CTSB (0.43) TDP1
SCHEMBL14465955 0.76 CYSLTR2 (0.36)
SCHEMBL23662479 0.76 KIF11 (0.38) KIF11
SCHEMBL9520131 0.76 CYSLTR2 (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5883102-A Pharmaceutically active compounds ASTRA PHARMACEUTICALS LIMITED (GB) 1999-03-16 US disclosed
EP-0858451-A1 PHARMACEUTICALLY ACTIVE QUINAZOLINE COMPOUNDS Astra Pharmaceuticals Limited (GB) 1998-08-19 EP disclosed
WO-1997014686-A1 PHARMACEUTICALLY ACTIVE QUINAZOLINE COMPOUNDS ASTRA PHARMACEUTICALS LIMITED (GB) 1997-04-24 WO disclosed
US-5236947-A Side effect reduction JOUVEINAL S.A. (FR) 1993-08-17 US disclosed